Testing effectiveness (Phase 2)Active Not RecruitingNCT06305767
What this trial is testing
A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005)
Who this might be right for
Bladder Cancer
Merck Sharp & Dohme LLC 230